Anthony Good - Imugene VP Research
| IUGNF Stock | USD 0.05 0 5.00% |
Insider
Anthony Good is VP Research of Imugene Limited
| Phone | 61 3 9824 5254 |
| Web | https://www.imugene.com |
Imugene Management Efficiency
The company has return on total asset (ROA) of (0.2148) % which means that it has lost $0.2148 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3718) %, meaning that it generated substantial loss on money invested by shareholders. Imugene's management efficiency ratios could be used to measure how well Imugene manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Lex Knol | Barloworld Ltd ADR | 68 | |
| Paul Konikowski | Via Renewables | 51 | |
| PDBA Bcom | Barloworld Ltd ADR | 50 | |
| Tantaswa Fubu | Barloworld Ltd ADR | 50 | |
| Christopher Wierenga | Barloworld Ltd ADR | 46 | |
| Charles MBA | Barloworld Ltd ADR | 66 | |
| William III | Via Renewables | 58 | |
| Stephen Rabalais | Via Renewables | N/A | |
| HDip CA | Barloworld Ltd ADR | 54 | |
| Emmanuel BSc | Barloworld Ltd ADR | 54 | |
| Barbara Clay | Via Renewables | 52 | |
| Mike Barajas | Via Renewables | 39 | |
| Litha Nkombisa | Barloworld Ltd ADR | 56 | |
| Michael Kuznar | Via Renewables | N/A | |
| Dominic BSc | Barloworld Ltd ADR | 57 | |
Management Performance
| Return On Equity | -0.37 | |||
| Return On Asset | -0.21 |
Imugene Limited Leadership Team
Elected by the shareholders, the Imugene's board of directors comprises two types of representatives: Imugene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imugene. The board's role is to monitor Imugene's management team and ensure that shareholders' interests are well served. Imugene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imugene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA ASiA, Ex Chairman | ||
| Charles Walker, Non-Executive Director | ||
| Anthony Good, VP Research | ||
| Paul Hopper, Executive Chairman of the Board | ||
| Nathan CA, Joint Sec | ||
| Ursula Wiedermann, Chief Scientific Officer | ||
| PharmD MBA, Chief Officer | ||
| Justyn Stedwell, Joint Company Secretary | ||
| Leslie Chong, CEO, Managing Director | ||
| Ursula McCurry, VP Operations | ||
| Mark Marino, Chief Medical Officer | ||
| Lesley Russell, Non-Executive Director | ||
| Phillip Hains, Joint Company Secretary | ||
| Giovanni Selvaggi, Chief Officer | ||
| ACA BSc, Chief Officer | ||
| Jens Eckstein, Non-Executive Director | ||
| Dr BSc, Chief Officer |
Imugene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Imugene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.37 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (2.92) % | |||
| Operating Margin | (2.91) % | |||
| Current Valuation | 737.79 M | |||
| Shares Outstanding | 6.42 B | |||
| Shares Owned By Insiders | 15.40 % | |||
| Shares Owned By Institutions | 8.67 % | |||
| Price To Book | 8.51 X | |||
| Price To Sales | 61.84 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Imugene Pink Sheet analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |